23 research outputs found
Accuracy of Five Serologic Tests for the Follow up of Strongyloides stercoralis Infection
BACKGROUND: Traditional faecal-based methods have poor
sensitivity for the detection of S. stercoralis, therefore are
inadequate for post-treatment evaluation of infected patients
who should be carefully monitored to exclude the persistence of
the infection. In a previous study, we demonstrated high
accuracy of five serology tests for the screening and diagnosis
of strongyloidiasis. Aim of this study is to evaluate the
performance of the same five tests for the follow up of patients
infected with S. stercoralis. METHODS: Retrospective study on
anonymized, cryo-preserved samples available at the Centre for
Tropical Diseases (Negrar, Verona, Italy). Samples were
collected before and from 3 to 12 months after treatment. The
samples were tested with two commercially-available ELISA tests
(IVD, Bordier), two techniques based on a recombinant antigen
(NIE-ELISA and NIE-LIPS) and one in-house IFAT. The results of
each test were evaluated both in relation to the results of
fecal examination and to those of a composite reference standard
(classifying as positive a sample with positive stools and/or at
least three positive serology tests). The associations between
the independent variables age and time and the dependent
variable value of serological test (for all five tests), were
analyzed by linear mixed-effects regression model. RESULTS: A
high proportion of samples demonstrated for each test a
seroreversion or a relevant decline (optical density/relative
light units halved or decrease of at least two titers for IFAT)
at follow up, results confirmed by the linear mixed effects
model that showed a trend to seroreversion over time for all
tests. In particular, IVD-ELISA (almost 90% samples demonstrated
relevant decline) and IFAT (almost 87%) had the best
performance. Considering only samples with a complete
negativization, NIE-ELISA showed the best performance (72.5%
seroreversion). CONCLUSIONS: Serology is useful for the follow
up of patients infected with S. stercoralis and determining test
of cure
Diagnostic accuracy of five serologic tests for Strongyloides stercoralis infection.
Background: The diagnosis of Strongyloides stercoralis (S. stercoralis) infection is hampered by the suboptimal sensitivity of fecal-based tests. Serological methods are believed to be more sensitive, although assessing their accuracy is difficult because of the lack of sensitivity of a fecal-based reference ('gold') standard. Methods: The sensitivity and specificity of 5 serologic tests for S. stercoralis (in-house IFAT, NIE-ELISA and NIE-LIPS and the commercially available Bordier-ELISA and IVD-ELISA) were assessed on 399 cryopreserved serum samples. Accuracy was measured using fecal results as the primary reference standard, but also using a composite reference standard (based on a combination of tests). Results: According to the latter standard, the most sensitive test was IFAT, with 94.6% sensitivity (91.2-96.9), followed by IVD-ELISA (92.3%, 87.7-96.9). The most specific test was NIE-LIPS, with specificity 99.6% (98.9-100), followed by IVD-ELISA (97.4%, 95.5-99.3). NIE-LIPS did not cross-react with any of the specimens from subjects with other parasitic infections. NIE-LIPS and the two commercial ELISAs approach 100% specificity at a cut off level that maintains â„70% sensitivity. Conclusions: NIE-LIPS is the most accurate serologic test for the diagnosis of S. stercoralis infection. IFAT and each of the ELISA tests are sufficiently accurate, above a given cut off, for diagnosis, prevalence studies and inclusion in clinical trials
Epidemiology of American Tegumentary Leishmaniasis and Trypanosoma cruzi Infection in the Northwestern Argentina
Background. Endemic areas of tegumentary leishmaniasis (TL) in Salta, Argentina, present some overlap zones with the geographical distribution of Chagas disease, with mixed infection cases being often detected. Objectives. The purpose of this study was to determine the magnitude of Leishmania sp. infection and potential associated risk factors, the serologic prevalence of T. cruzi, and the presence of T. cruzi-Leishmania sp. mixed infection in a region of the northwest of Argentina. Methods. Crosssectional studies were conducted to detect TL prevalence and T. cruzi seroprevalence. A case-control study was conducted to examine leishmaniasis risk factors. Results. Prevalence of TL was 0.17%, seroprevalence of T. cruzi infection was 9.73%, and mixed infection proportion-within the leishmaniasic patients group-was 16.67%. The risk factors associated with TL transmission were sex, age, exposure to bites at work, staying outdoors more than 10 hours/day, bathing in the river, and living with people who had lesions or were infected during the study. Discussion. The endemic pattern of TL seems to involve exposure of patients to vectors in wild as well as peridomestic environment. Cases of T. cruzi infection are apparently due to migration. Therefore, a careful epidemiological surveillance is necessary due to the contraindication of antimonial administration to chagasic patients
Effects of IFN-Îł coding plasmid supplementation in the immune response and protection elicited by Trypanosoma cruzi attenuated parasites
Abstract Background Previous studies showed that a naturally attenuated strain from Trypanosoma cruzi triggers an immune response mainly related to a Th2-type profile. Albeit this, a strong protection against virulent challenge was obtained after priming mice with this attenuated strain. However, this protection is not enough to completely clear parasites from the host. In T. cruzi infection, early Interferon-gamma (IFN-Îł) is critical to lead type 1 responses able to control intracellular parasites. Therefore we evaluated whether the co-administration of a plasmid encoding murine IFN-Îł could modify the immune response induced by infection with attenuated parasites and improve protection against further infections. Methods C57BL/6J mice were infected intraperitoneally with three doses of live attenuated parasites in combination with plasmid pVXVR-mIFN-Îł. Before each infection dose, sera samples were collected for parasite specific antibodies determination and cytokine quantification. To evaluate the recall response to T. cruzi, mice were challenged with virulent parasites 30 days after the last dose and parasite load in peripheral blood and heart was evaluated. Results As determined by ELISA, significantly increase in T. cruzi specific antibodies response was detected in the group in which pVXVR-mIFN-Îł was incorporated, with a higher predominance of IgG2a subtype in comparison to the group of mice only inoculated with attenuated parasites. At our limit of detection, serum levels of IFN-Îł were not detected, however a slight decrease in IL-10 concentrations was observed in groups in which pVXVR-mIFN-Îł was supplemented. To analyze if the administration of pVXVR-mIFN-Îł has any beneficial effect in protection against subsequent infections, all experimental groups were submitted to a lethal challenge with virulent bloodstream trypomastigotes. Similar levels of challenge parasites were detected in peripheral blood and heart of mice primed with attenuated parasites alone or combined with plasmid DNA. Expansion of IgG antibodies was not significant in TCC+ pVXVR-mIFN-Îł; however, the overall tendency to sustain a Th2 profile was maintained. Conclusions Overall, these results suggest that administration of plasmid pVXVR-mIFN-Îł could have beneficial effects on host specific antibody production in response to T. cruzi attenuated infection; however, this outcome is not reflected in an improved protection against further virulent infections
A monoallelic deletion of the TcCRT gene increases the attenuation of a cultured Trypanosoma cruzi strain, protecting against an in vivo virulent challenge.
Trypanosoma cruzi calreticulin (TcCRT) is a virulence factor that binds complement C1, thus inhibiting the activation of the classical complement pathway and generating pro-phagocytic signals that increase parasite infectivity. In a previous work, we characterized a clonal cell line lacking one TcCRT allele (TcCRT+/-) and another overexpressing it (TcCRT+), both derived from the attenuated TCC T. cruzi strain. The TcCRT+/- mutant was highly susceptible to killing by the complement machinery and presented a remarkable reduced propagation and differentiation rate both in vitro and in vivo. In this report, we have extended these studies to assess, in a mouse model of disease, the virulence, immunogenicity and safety of the mutant as an experimental vaccine. Balb/c mice were inoculated with TcCRT+/- parasites and followed-up during a 6-month period. Mutant parasites were not detected by sensitive techniques, even after mice immune suppression. Total anti-T. cruzi IgG levels were undetectable in TcCRT+/- inoculated mice and the genetic alteration was stable after long-term infection and it did not revert back to wild type form. Most importantly, immunization with TcCRT+/- parasites induces a highly protective response after challenge with a virulent T. cruzi strain, as evidenced by lower parasite density, mortality, spleen index and tissue inflammatory response. TcCRT+/- clones are restricted in two important properties conferred by TcCRT and indirectly by C1q: their ability to evade the host immune response and their virulence. Therefore, deletion of one copy of the TcCRT gene in the attenuated TCC strain generated a safe and irreversibly gene-deleted live attenuated parasite with high immunoprotective properties. Our results also contribute to endorse the important role of TcCRT as a T. cruzi virulence factor
Urban Transmission of American Cutaneous Leishmaniasis in Argentina: Spatial Analysis Study
We used kernel density and scan statistics to examine the spatial distribution of cases of pediatric and adult American cutaneous leishmaniasis in an urban disease-endemic area in Salta Province, Argentina. Spatial analysis was used for the whole population and stratified by women > 14 years of age (n = 159), men > 14 years of age (n = 667), and children < 15 years of age (n = 213). Although kernel density for adults encompassed nearly the entire city, distribution in children was most prevalent in the peripheral areas of the city. Scan statistic analysis for adult males, adult females, and children found 11, 2, and 8 clusters, respectively. Clusters for children had the highest odds ratios (P < 0.05) and were located in proximity of plantations and secondary vegetation. The data from this study provide further evidence of the potential urban transmission of American cutaneous leishmaniasis in northern Argentina
TcCRT+/â mutant parasites are stable after prolonged infection in mice.
<p>(A) Schematic representation of the TcCRT genomic locus in TcCRT+/â parasites (B) PCR analysis carried out from genomic DNA of TcCRT+/â and wild type parasites recovered from hemocultures of chronically infected mice. Primers: Pair CRT1-CRT2 and H1-H2 amplify the TcCRT (1.2 KB) and HYG CDS (0.96 kb), respectively. Pair CRT7-H4 amplifies the 5' UTR of TcCRT together with a fragment of the HYG CDS (1.45 kb). Pair CRT93-H6 amplifies the 3' UTR of TcCRT together with a fragment of the HYG CDS (1.4 kb). The sizes of the fragments correspond to those predicted for the replacement of TcCRT by the HYG gene.</p
Infectivity and persistence of TcCRT mutants in Balb/c and nude mice.
<p>Infectivity in mice infected with 5Ă10<sup>5</sup> metacyclic TcCRT+/â, wild type and TcCRT+ trypomastigote clones in Balb/c and nude mice, as detected by hemoculture and PCR. NDâ=â not done. Numbers in the third line refer to days p.i. (*) samples obtained after cyclophosphamide immunosuppression.</p
TcCRT+/â inoculated mice showed significant reduction of specific anti <i>T. cruzi</i> antibody levels.
<p>BALB/c mice were inoculated with 5Ă10<sup>5</sup> metacyclic trypomastigotes. Results are expressed as the ratio of the absorbance of each serum sample at 490-nm. Dotted lines: Cut-off value adopted for positivity calculated as the mean of the values obtained for the negative controls (inoculated with PBS) plus three times the standard deviation. Serum samples were taken at the intervals indicated. TcCRT+/â inoculated mice showed significant reduction of antibody levels compared to those inoculated with wild type and TcCRT+ clones (pâ=â0.01 for both cases). Positive controls: serum from mice infected with the virulent TulahuĂ©n <i>T. cruzi</i> strain.</p